The TDP-43 protein plays a role in a broad suite of neurodegenerative disorders including Frontotemporal lobar degeneration (FTLD), amyotrophic lateral sclerosis, and potentially Alzheimer's disease. TDP-43 is a multifunctional protein with many known cellular roles. So while the importance of TDP-43 in neurodegeneration is established, the mechanisms of TDP-43 toxicity are unclear. We have discovered a new role for TDP-43 in regulating retrotransposons. Retrotransposons are virus-like sequences that are encoded in our genomes and are capable of replicating and inserting at new chromosomal positions. The toxic potential of transposons in the germline is established. So our discovery provides a plausible hypothesis for toxic effects of TDP-43 in neurons. Our preliminary studies provide evidence that TDP-43 normally helps to silence transposons and that this function is disrupted both in FTLD patients and a Drosophila disease model. Our proposed experiments will use next generation RNA-sequencing with brain samples from FTLD patients to profile expression of retrotransposons. We also will examine the small RNAS a chromatin mark that normally help to silence retrotransposons. We will test three specific hypotheses: 1- that retrotransposon expression is increased in FTLD and ALS brain tissue. 2- that small RNA silencing of retrotransposons is perturbed in FTLD and ALS brain 2- that H3K9me histone silencing mark is perturbed in FTLD and ALS brain tissue

Public Health Relevance

TDP-43 is a protein with a central role in several devastating neurodegenerative disorders, including Frontotemporal Lobar Degeneration, Amyotrophic Lateral Sclerosis, and potentially in Alzheimer's disease. We have discovered a new role for TDP-43 in regulating transposons, which are virus-like elements that are present and inherited in the human genome. This proposal will test the hypothesis that re-awakening of these ancient transposons occurs in cortical tissue from subjects with frontotemporal lobar degeneration and in spinal cord from patients with amyotrophic lateral sclerosis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21NS088449-02
Application #
9087363
Study Section
Cellular and Molecular Biology of Neurodegeneration Study Section (CMND)
Program Officer
Sutherland, Margaret L
Project Start
2015-07-01
Project End
2017-06-30
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
2
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Cold Spring Harbor Laboratory
Department
Type
DUNS #
065968786
City
Cold Spring Harbor
State
NY
Country
United States
Zip Code
11724
O'Neill, Kathryn; Liao, Wen-Wei; Patel, Ami et al. (2018) TEsmall Identifies Small RNAs Associated With Targeted Inhibitor Resistance in Melanoma. Front Genet 9:461